Hudson Bay Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.21M | Buy |
157,786
+10,523
| +7% | +$348K | 0.02% | 384 |
|
|
2025
Q1 | $5.92M | Buy |
147,263
+5,994
| +4% | +$241K | 0.02% | 323 |
|
|
2024
Q4 | $6.65M | Buy |
141,269
+73,769
| +109% | +$3.47M | 0.02% | 311 |
|
|
2024
Q3 | $3.56M | Buy |
67,500
+37,500
| +125% | +$1.98M | 0.01% | 357 |
|
|
2024
Q2 | $1.63M | Sell |
30,000
-217,566
| -88% | -$11.8M | 0.01% | 442 |
|
|
2024
Q1 | $17.4M | Buy |
+247,566
| New | +$17.4M | 0.1% | 83 |
|
|
2023
Q4 | – | Sell |
-80,000
| Closed | -$2.36M | – | 684 |
|
|
2023
Q3 | $2.36M | Buy |
80,000
+60,000
| +300% | +$1.77M | 0.02% | 388 |
|
|
2023
Q2 | $652K | Buy |
+20,000
| New | +$652K | ﹤0.01% | 547 |
|
|
2020
Q3 | – | Sell |
-50,000
| Closed | -$1.18M | – | 552 |
|
|
2020
Q2 | $1.18M | Sell |
50,000
-125,000
| -71% | -$2.95M | 0.02% | 354 |
|
|
2020
Q1 | $2.06M | Sell |
175,000
-50,000
| -22% | -$589K | 0.05% | 252 |
|
|
2019
Q4 | $2.39M | Buy |
+225,000
| New | +$2.39M | 0.05% | 243 |
|